British watchdog clears AstraZeneca buyout for $ 39 billion by AstraZeneca

July 14 (Reuters) – Britain’s competition regulator on Wednesday said it had cleared AstraZeneca (AZN.L) to buy $ 39 billion from US company Alexion (ALXN.O) after deciding not to launch an investigation broader on the deal after its initial assessment.

The Competition and Markets Authority has started reviewing the takeover slated for May to see if it could reduce competition in Britain or other markets. Its clearance follows that of Europe earlier this month.

Report by Pushkala Aripaka in Bangalore; Editing by Arun Koyyur

Our Standards: The Thomson Reuters Trust Principles.